TN-01

Recruiting
99 years or below
All
Phase N/A
15 participants needed
1 Location

Brief description of study

Through participation in this study, UPenn will become a TrialNet Natural History Study affiliate site. TrialNet, (short title) began in 2004 and has screened over 240,000 family members for diabetes related antibodies. This specific Pathway to Prevention TrialNet study (TN-01) plans to perform baseline and repeat assessments over time in a population of adults (18+) in order to confirm immunologic status of individuals at risk for type 1 diabetes. The study is divided into a Screening and a Monitoring stage. Each stage will use a separate Informed Consent document for enrollment.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 05 Oct 2026. Study ID: 26-6950

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center